Universe Pharmaceuticals (NYSE:UPC) Trading Down 4.3% – What’s Next?

Universe Pharmaceuticals INC (NYSE:UPC)’s share price fell 4.3% on Wednesday . The stock traded as low as $0.13 and last traded at $0.13. 534,055 shares changed hands during mid-day trading, a decline of 84% from the average session volume of 3,395,690 shares. The stock had previously closed at $0.14.

Universe Pharmaceuticals Stock Performance

The stock has a 50-day moving average of $0.33 and a two-hundred day moving average of $6.18.

Hedge Funds Weigh In On Universe Pharmaceuticals

A hedge fund recently bought a new stake in Universe Pharmaceuticals stock. MML Investors Services LLC acquired a new stake in shares of Universe Pharmaceuticals INC (NYSE:UPC) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 234,260 shares of the company’s stock, valued at approximately $57,000. MML Investors Services LLC owned approximately 6.46% of Universe Pharmaceuticals as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 0.18% of the company’s stock.

Universe Pharmaceuticals Company Profile

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.